DMAIC · Pharmaceutical QC / Stability Lab
OOS investigation cycle time at QC Stability Lab
From 18.2 days to 5.8 — 92% of investigations within the 7-day SLA, ~$255K/yr recovered.
Problem
OOS (Out-of-Spec) investigation cycle time at the QC Stability Lab averaged 18.2 days over the prior quarter against a 7-day SLA. 60% of investigations breached the SLA, delaying batch release an average of 9 days per affected lot and driving ~$285K/yr in customer credit notes and delayed-release inventory carry. Off-site stability sample storage went live the previous quarter; the OOS Investigation SOP was never updated to reflect the new retrieval workflow.
Goal
Reduce mean OOS investigation cycle time from 18.2 days to ≤7.0 days with ≥90% of investigations within SLA, sustained for 8 consecutive weeks.
Mean OOS investigation cycle time
Baseline
18.2 days
Target
≤7.0 days
Result
5.8 days (8 wk sustained · 92% within SLA)
Key artifacts generated in Taktly
Project Charter
Problem, scope (QC Stability Lab · all instruments · all product lines), 18.2 → 7.0 days, $255K/yr savings model, sponsor-approved.
Process Map (Operator → Supervisor → Quality)
9 steps across 3 lanes. Steps 3–4 (sample retrieval) flagged as the cycle-time loss zone (4–6 days of every cycle).
5-Why Root Cause
No named owner for the OOS Investigation SOP since the QA Documentation Manager role was eliminated. A LIMS auto-retrieval feature ready for 14 months sat behind a missing signature.
Standardization Plan
SOP v3 published · LIMS auto-trigger enabled · QA SOP Owner role created · 12 high-volume SKUs pre-staged on-site · Tier-1 KPI on QA huddle board.
What we did
- Charter + 5W2H + Define Observations across 5 sources (Lab Manager, Senior Analyst, Sample Custody, LIMS Admin, QA Director) — all five voices converged on the SOP-currency gap.
- Pareto of 184 cycle-time overruns: sample retrieval delay = 49% of the loss; top 3 causes = 82%. Run chart confirmed the process was stable but operating above the 7-day SLA every week.
- Hypothesis ledger: H1 (retrieval delay) + H2 (SOP not updated) confirmed; H3 (LIMS feature dormant) marked Contributing — both Yes and Contributing flowed into the 5-Why chain.
- Improve register with CA/PA/Remedial classification: enable LIMS auto-trigger (Corrective), publish SOP v3 (Corrective), name a QA SOP Owner with quarterly cadence (Preventive), pre-stage SKUs (Remedial), 60-day daily huddle (Remedial). CAPA quality gate passed 9/9 on selected actions.
- Welch's t-test on before vs after cycle times: p < 0.001, Cohen's d > 1.5 — improvement confirmed and practically large. Customer credit notes for QC-related delays trended to zero by week 6.
Outcome
Mean OOS investigation cycle time dropped 68% (18.2 → 5.8 days) and held there for 8 consecutive weeks. SLA achievement rose from 40% to 92%, exceeding the ≥90% success criterion. Annualized cost recovery: ~$255K from eliminated customer credits and faster batch release. The QA SOP Owner role is now active; the same SOP-currency review cadence is being rolled out across the other two stability lab sites.